Delphi-Based Consensus on Interstitial Lung Disease Screening in Patients with Connective Tissue Diseases (Croatian National-Based Study)
Mislav Radić,
Srđan Novak,
Marko Barešić,
Ana Hećimović,
Dijana Perković,
Jasna Tekavec-Trkanjec,
Miroslav Mayer,
Višnja Prus,
Jadranka Morović-Vergles,
Daniela Marasović Krstulović,
Mislav Cerovec,
Ljiljana Bulat Kardum,
Miroslav Samaržija,
Branimir Anić
Affiliations
Mislav Radić
Division of Rheumatology and Clinical Immunology, Centre of Excellence for Systemic Sclerosis Ministry of Health Republic of Croatia, University Hospital Centre Split, 21000 Split, Croatia
Srđan Novak
Department of Rheumatology and Clinical Immunology, University Hospital Center Rijeka, 51000 Rijeka, Croatia
Marko Barešić
Division of Clinical Immunology and Rheumatology, Department of Internal Medicine, University Hospital Center Zagreb, 10000 Zagreb, Croatia
Ana Hećimović
School of Medicine, University of Zagreb, 10000 Zagreb, Croatia
Dijana Perković
Division of Rheumatology and Clinical Immunology, Centre of Excellence for Systemic Sclerosis Ministry of Health Republic of Croatia, University Hospital Centre Split, 21000 Split, Croatia
Jasna Tekavec-Trkanjec
Department of Pneumonology, Dubrava University Hospital, 10000 Zagreb, Croatia
Miroslav Mayer
Division of Clinical Immunology and Rheumatology, Department of Internal Medicine, University Hospital Center Zagreb, 10000 Zagreb, Croatia
Višnja Prus
Department of Rheumatology, Clinical Immunology and Allergology, University Hospital Center Osijek, 31000 Osijek, Croatia
Jadranka Morović-Vergles
School of Medicine, University of Zagreb, 10000 Zagreb, Croatia
Daniela Marasović Krstulović
Division of Rheumatology and Clinical Immunology, Centre of Excellence for Systemic Sclerosis Ministry of Health Republic of Croatia, University Hospital Centre Split, 21000 Split, Croatia
Mislav Cerovec
Department for Rheumatology, Special Hospital Primamed, 10000 Zagreb, Croatia
Ljiljana Bulat Kardum
Department of Rheumatology and Clinical Immunology, University Hospital Center Rijeka, 51000 Rijeka, Croatia
Miroslav Samaržija
School of Medicine, University of Zagreb, 10000 Zagreb, Croatia
Branimir Anić
Division of Clinical Immunology and Rheumatology, Department of Internal Medicine, University Hospital Center Zagreb, 10000 Zagreb, Croatia
The aim of this study was to develop a Croatian Delphi-based expert consensus for screening interstitial lung disease (ILD) associated with connective tissue disease (CTD). A systematic literature review was conducted on risk factors for the development of ILD, prevalence and incidence of ILD, diagnostic and screening methods for ILD, and prognosis of ILD in idiopathic inflammatory myopathy (IIM), mixed connective tissue disease (MCTD), primary Sjögren’s syndrome (pSS), rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and systemic sclerosis (SSc) were performed. Based on the evidence found, experts developed questionnaires for screening and monitoring ILD in each CTD, which were provided via an online survey. Following the electronic survey, two screening algorithms were developed based on the consensus opinions. The detection strategy for ILD included high-resolution computed tomography (HRCT) in addition to pulmonary function testing for IIM, MCTD, and SSc. and pulmonary function testing for newly diagnosed pSS, RA and SLE. However, in patients with identified risk factors for ILD HRCT, these tests should also be performed. A screening strategy for early identification of patients with various CTD-ILD was first developed by a multidisciplinary team of rheumatologists, pulmonologists, and radiologists to identify early CTD patients at risk of ILD, a severe extra-articular manifestation of CTD.